Abstract
Objective
The dural tail sign was first described as a thin, tapering rim of dural enhancement, in continuity with meningiomas on enhanced T1-weighted magnetic resonance (MR) images. However, the exact nature of the dural tail is still unclear. This study investigated the immunohistochemical (IHC) characteristics of the dural tail in intracranial meningiomas and the correlation between clinicopathological profiles and tumor invasion of the dural tail.
Methods
The study group consisted of 36 patients of meningioma with the dural tail noted on MR imaging and in pathological findings, and 18 patients of meningioma without the dural tail as the control group. IHC staining of tumor masses and dural tails for vascular endothelial growth factor (VEGF), epithelial membrane antigen, CD34, Ki-67, and vimentin were performed.
Results
The data showed that 61.1 % (22/36) of cases in the study group revealed tumor invasion of dural tail, and 55.6 % (30/54) of all the cases demonstrated dura mater invasion in all the samples. The dura mater invasion was significantly positively related to invasion of the dural tail in the study group (p = 0.009). IHC staining detected higher expression of VEGF and CD34 in the dural tail than in the main tumor mass.
Conclusions
Considering the high proportion of patients with tumor invasion into the dural tail, we tried to perform wide resection of the dural tail during intracranial meningioma surgery. Furthermore, VEGF was strongly expressed in tumor cells that invaded into the dural tail, and hence VEGF can be used as a marker to differentiate tumor cells from normal meningeal cells in the dural tail.
Similar content being viewed by others
Abbreviations
- EMA:
-
Epithelial membrane antigen
- IHC:
-
Immunohistochemistry
- MR:
-
Magnetic resonance
- MVD:
-
Microvessel density
- VEGF:
-
Vascular endothelial growth factor
References
Abdelzaher E, Mohamed Abdallah D (2014) Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int 2014:7
Arana E, Marti-Bonmati L, Ricart V, Pérez-Ebrí M (2004) Dural enhancement with primary calvarial lesions. Neuroradiology 46:900–905
Barresi V, Cerasoli S, Vitarelli E, Tuccari G (2007) Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147–156
Barresi V, Vitarelli E, Cerasoli S (2009) Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch 454:563–571
Borovich B, Doron Y (1986) Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64:58–63
Borovich B, Doron Y, Braun J, Feinsod M, Goldsher D, Gruszkiewicz J, Guilburd J, Zaaroor M, Levi L, Soustiel J (1988) The incidence of multiple meningiomas—Do solitary meningiomas exist? Acta Neurochir (Wien) 90:15–22
Christov C, Lechapt-Zalcman E, Adle-Biassette H, Nachev S, Gherardi RK (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420
Cordell J, Richardson T, Pulford K, Ghosh A, Gatter K, Heyderman E, Mason D (1985) Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 52:347
Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25
Goldsher D, Litt A, Pinto R, Bannon K, Kricheff I (1990) Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications for treatment. Radiology 176:447–450
Guermazi A, Lafitte F, Miaux Y, Adem C, Bonneville JF, Chiras J (2005) The dural tail sign–beyond meningioma. Clin Radiol 60:171–188
Heyderman E, Steele K, Ormerod M (1979) A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue. J Clin Pathol 32:35–39
Hiyama H, Kubo O, Tajika Y, Tohyama T, Takakura K (1994) Meningiomas associated with peritumoural venous stasis: three types on cerebral angiogram. Acta Neurochir (Wien) 129:31–38
Hutzelmann A, Palmie S, Buhl R, Freund M, Heller M (1998) Dural invasion of meningiomas adjacent to the tumor margin on Gd-DTPA-enhanced MR images: histopathologic correlation. Eur Radiol 8:746–748
Jensen R, Lee J (2012) Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery 71:146–156
Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM (1996) Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85:1095–1101
Kawahara Y, Niiro M, Yokoyama S, Kuratsu J (2001) Dural congestion accompanying meningioma invasion into vessels: the dural tail sign. Neuroradiology 43:462–465
Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309–1312
Larson J, Tew J Jr, Wiot J, de Courten-Myers G (1992) Association of meningiomas with dural “tails”; surgical significance. Acta Neurochir (Wien) 114:59–63
Ng H, Tse CC, Lo ST (1987) Meningiomas and arachnoid cells: an immunohistochemical study of epithelial markers. Pathology 19:253–257
Nielsen JS, McNagny KM (2008) Novel functions of the CD34 family. J Cell Sci 121:3683–3692
Otsuka S, Tamiya T, Ono Y, Michiue H, Kurozumi K, Daido S, Kambara H, Date I, Ohmoto T (2004) The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J Neurooncol 70:349–357
Pinkus GS, Kurtin PJ (1985) Epithelial membrane antigen—a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 16:929–940
Pistolesi S, Fontanini G, Camacci T, De Ieso K, Boldrini L, Lupi G, Padolecchia R, Pingitore R, Parenti G (2002) Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply. J Neurooncol 60:159–164
Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate KH, Widhalm G, Knosp E, Breitschopf H, Berger J (2012) Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches. Clin Neuropathol 31:351–360
Provias J, Claffey K, Lau N, Feldkamp M, Guha A (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026
S-t Q, Liu Y, Pan J, Chotai S, Fang L-x (2012) A radiopathological classification of dural tail sign of meningiomas: laboratory investigation. J Neurosurg 117:645–653
Rokni-Yazdi H, Azmoudeh Ardalan F, Asadzandi Z, Sotoudeh H, Shakiba M, Adibi A, Ayatollahi H, Rahmani M (2009) Pathologic significance of the “dural tail sign”. Eur J Radiol 70:10–16
Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189–1193
Schörner W, Schubeus P, Henkes H, Lanksch W, Felix R (1990) ““Meningeal sign”: a characteristic finding of meningiomas on contrast-enhanced MR images. Neuroradiology 32:90–93
Schmid S, Aboul-Enein F, Pfisterer W, Birkner T, Stadek C, Knosp E (2010) Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients. Neurosurgery 67:1703–1708
Schnitt SJ, Vogel H (1986) Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol 10:640–649
Sekiya T, Manabe H, Iwabuchi T, Narita T (1992) The dura mater adjacent to the attachment of meningiomas: its enhanced MR imaging and histological findings. No Shinkei Geka 20:1063
Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–985
Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560–566
Tokumaru A, O'uchi T, Eguchi T, Kawamoto S, Kokubo T, Suzuki M, Kameda T (1990) Prominent meningeal enhancement adjacent to meningioma on Gd-DTPA-enhanced MR images: histopathologic correlation. Radiology 175:431–433
Wilms G, Lammens M, Marchal G, Van Calenbergh F, Plets C, Van Fraeyenhoven L, Baert AL (1989) Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr 13:763–768
Winek RR, Scheithauer BW, Wick MR (1989) Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma: a comparative immunohistochemical study. Am J Surg Pathol 13:251–261
Yamasaki F, Yoshioka H, Hama S, Sugiyama K, Arita K, Kurisu K (2000) Recurrence of meningiomas. Cancer 89:1102–1110
Acknowledgments
This study was supported by a grant (CRI 11044–1) of the Chonnam National University Hospital Research Institute of Clinical Medicine.
Conflicts of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wen, M., Jung, S., Moon, KS. et al. Immunohistochemical profile of the dural tail in intracranial meningiomas. Acta Neurochir 156, 2263–2273 (2014). https://doi.org/10.1007/s00701-014-2216-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-014-2216-4